nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—malignant glioma	0.407	0.54	CbGaD
Pethidine—SLC6A3—malignant glioma	0.347	0.46	CbGaD
Pethidine—GRIN1—telencephalic ventricle—malignant glioma	0.00869	0.0812	CbGeAlD
Pethidine—GRIN2B—telencephalic ventricle—malignant glioma	0.00829	0.0775	CbGeAlD
Pethidine—ORM1—vertebral column—malignant glioma	0.00519	0.0485	CbGeAlD
Pethidine—OPRM1—telencephalic ventricle—malignant glioma	0.00441	0.0412	CbGeAlD
Pethidine—SLC6A3—telencephalic ventricle—malignant glioma	0.004	0.0374	CbGeAlD
Pethidine—Fibrosis—Carmustine—malignant glioma	0.00366	0.108	CcSEcCtD
Pethidine—GRIN2C—brainstem—malignant glioma	0.00284	0.0265	CbGeAlD
Pethidine—GRIN2D—brainstem—malignant glioma	0.00264	0.0247	CbGeAlD
Pethidine—GRIN2C—telencephalon—malignant glioma	0.00252	0.0235	CbGeAlD
Pethidine—GRIN1—brainstem—malignant glioma	0.00235	0.022	CbGeAlD
Pethidine—GRIN2D—telencephalon—malignant glioma	0.00234	0.0219	CbGeAlD
Pethidine—GRIN2B—brainstem—malignant glioma	0.00224	0.021	CbGeAlD
Pethidine—GRIN1—telencephalon—malignant glioma	0.00209	0.0195	CbGeAlD
Pethidine—Ketobemidone—CYP2B6—malignant glioma	0.00202	0.406	CrCbGaD
Pethidine—GRIN2B—telencephalon—malignant glioma	0.00199	0.0186	CbGeAlD
Pethidine—GRIN2C—medulla oblongata—malignant glioma	0.00198	0.0185	CbGeAlD
Pethidine—GRIN2A—brainstem—malignant glioma	0.00196	0.0183	CbGeAlD
Pethidine—GRIN2D—medulla oblongata—malignant glioma	0.00184	0.0172	CbGeAlD
Pethidine—GRIN2A—telencephalon—malignant glioma	0.00174	0.0163	CbGeAlD
Pethidine—GRIN2D—spinal cord—malignant glioma	0.00164	0.0153	CbGeAlD
Pethidine—Paranoia—Carmustine—malignant glioma	0.00154	0.0451	CcSEcCtD
Pethidine—GRIN1—midbrain—malignant glioma	0.0015	0.014	CbGeAlD
Pethidine—GRIN1—spinal cord—malignant glioma	0.00146	0.0137	CbGeAlD
Pethidine—GRIN2C—central nervous system—malignant glioma	0.00143	0.0134	CbGeAlD
Pethidine—GRIN2C—cerebellum—malignant glioma	0.0014	0.0131	CbGeAlD
Pethidine—GRIN2B—spinal cord—malignant glioma	0.0014	0.013	CbGeAlD
Pethidine—GRIN2A—medulla oblongata—malignant glioma	0.00137	0.0128	CbGeAlD
Pethidine—GRIN2D—central nervous system—malignant glioma	0.00133	0.0124	CbGeAlD
Pethidine—Ketobemidone—PTGS1—malignant glioma	0.00133	0.267	CrCbGaD
Pethidine—GRIN2D—cerebellum—malignant glioma	0.0013	0.0122	CbGeAlD
Pethidine—Injection site pain—Carmustine—malignant glioma	0.00128	0.0377	CcSEcCtD
Pethidine—GRIN2A—midbrain—malignant glioma	0.00125	0.0117	CbGeAlD
Pethidine—GRIN2A—spinal cord—malignant glioma	0.00122	0.0114	CbGeAlD
Pethidine—OPRM1—brainstem—malignant glioma	0.00119	0.0111	CbGeAlD
Pethidine—GRIN1—central nervous system—malignant glioma	0.00119	0.0111	CbGeAlD
Pethidine—GRIN1—cerebellum—malignant glioma	0.00116	0.0108	CbGeAlD
Pethidine—GRIN2C—brain—malignant glioma	0.00114	0.0106	CbGeAlD
Pethidine—GRIN2B—central nervous system—malignant glioma	0.00113	0.0106	CbGeAlD
Pethidine—GRIN2B—cerebellum—malignant glioma	0.00111	0.0103	CbGeAlD
Pethidine—SLC6A3—brainstem—malignant glioma	0.00108	0.0101	CbGeAlD
Pethidine—Coordination abnormal—Carmustine—malignant glioma	0.00107	0.0313	CcSEcCtD
Pethidine—OPRM1—telencephalon—malignant glioma	0.00106	0.00988	CbGeAlD
Pethidine—GRIN2D—brain—malignant glioma	0.00106	0.00987	CbGeAlD
Pethidine—Coordination abnormal—Temozolomide—malignant glioma	0.00103	0.0303	CcSEcCtD
Pethidine—Depressed level of consciousness—Carmustine—malignant glioma	0.00101	0.0297	CcSEcCtD
Pethidine—SLC6A4—brainstem—malignant glioma	0.000992	0.00926	CbGeAlD
Pethidine—GRIN2A—central nervous system—malignant glioma	0.000989	0.00924	CbGeAlD
Pethidine—Depressed level of consciousness—Temozolomide—malignant glioma	0.000977	0.0287	CcSEcCtD
Pethidine—GRIN2A—cerebellum—malignant glioma	0.000967	0.00903	CbGeAlD
Pethidine—SLC6A3—telencephalon—malignant glioma	0.00096	0.00897	CbGeAlD
Pethidine—Cyclopentolate—BCHE—malignant glioma	0.000957	0.192	CrCbGaD
Pethidine—Coma—Carmustine—malignant glioma	0.000956	0.0281	CcSEcCtD
Pethidine—GRIN1—brain—malignant glioma	0.000942	0.0088	CbGeAlD
Pethidine—GRIN2B—brain—malignant glioma	0.000899	0.00839	CbGeAlD
Pethidine—Phlebitis—Carmustine—malignant glioma	0.000882	0.0259	CcSEcCtD
Pethidine—SLC6A4—telencephalon—malignant glioma	0.00088	0.00822	CbGeAlD
Pethidine—SLC6A2—brainstem—malignant glioma	0.000873	0.00815	CbGeAlD
Pethidine—OPRK1—central nervous system—malignant glioma	0.000845	0.0079	CbGeAlD
Pethidine—OPRK1—cerebellum—malignant glioma	0.000826	0.00772	CbGeAlD
Pethidine—GRIN2A—brain—malignant glioma	0.000785	0.00734	CbGeAlD
Pethidine—SLC6A2—telencephalon—malignant glioma	0.000775	0.00724	CbGeAlD
Pethidine—OPRM1—midbrain—malignant glioma	0.00076	0.0071	CbGeAlD
Pethidine—OPRM1—spinal cord—malignant glioma	0.000741	0.00693	CbGeAlD
Pethidine—ORM1—spinal cord—malignant glioma	0.000724	0.00676	CbGeAlD
Pethidine—Affect lability—Temozolomide—malignant glioma	0.000723	0.0212	CcSEcCtD
Pethidine—Mood swings—Temozolomide—malignant glioma	0.000695	0.0204	CcSEcCtD
Pethidine—SLC6A3—midbrain—malignant glioma	0.00069	0.00644	CbGeAlD
Pethidine—Methylphenobarbital—CYP2B6—malignant glioma	0.000673	0.135	CrCbGaD
Pethidine—SLC6A3—spinal cord—malignant glioma	0.000673	0.00629	CbGeAlD
Pethidine—OPRK1—brain—malignant glioma	0.000671	0.00627	CbGeAlD
Pethidine—SLC6A4—midbrain—malignant glioma	0.000632	0.0059	CbGeAlD
Pethidine—SLC6A4—spinal cord—malignant glioma	0.000617	0.00576	CbGeAlD
Pethidine—SLC6A2—medulla oblongata—malignant glioma	0.000609	0.00569	CbGeAlD
Pethidine—OPRM1—central nervous system—malignant glioma	0.000601	0.00562	CbGeAlD
Pethidine—ORM1—central nervous system—malignant glioma	0.000587	0.00548	CbGeAlD
Pethidine—SLC6A3—central nervous system—malignant glioma	0.000546	0.0051	CbGeAlD
Pethidine—SLC6A3—cerebellum—malignant glioma	0.000533	0.00498	CbGeAlD
Pethidine—Hallucination—Carmustine—malignant glioma	0.000523	0.0154	CcSEcCtD
Pethidine—Visual impairment—Carmustine—malignant glioma	0.000506	0.0149	CcSEcCtD
Pethidine—Hallucination—Temozolomide—malignant glioma	0.000505	0.0149	CcSEcCtD
Pethidine—SLC6A4—central nervous system—malignant glioma	0.0005	0.00467	CbGeAlD
Pethidine—Visual impairment—Temozolomide—malignant glioma	0.000489	0.0144	CcSEcCtD
Pethidine—Flushing—Carmustine—malignant glioma	0.000488	0.0143	CcSEcCtD
Pethidine—CYP2D6—brainstem—malignant glioma	0.000478	0.00447	CbGeAlD
Pethidine—OPRM1—brain—malignant glioma	0.000477	0.00446	CbGeAlD
Pethidine—Flushing—Temozolomide—malignant glioma	0.000471	0.0139	CcSEcCtD
Pethidine—Erythema—Carmustine—malignant glioma	0.000458	0.0134	CcSEcCtD
Pethidine—Erythema—Temozolomide—malignant glioma	0.000442	0.013	CcSEcCtD
Pethidine—SLC6A2—central nervous system—malignant glioma	0.00044	0.00411	CbGeAlD
Pethidine—SLC6A3—brain—malignant glioma	0.000433	0.00405	CbGeAlD
Pethidine—Tremor—Carmustine—malignant glioma	0.000429	0.0126	CcSEcCtD
Pethidine—CYP2D6—telencephalon—malignant glioma	0.000424	0.00396	CbGeAlD
Pethidine—Agitation—Carmustine—malignant glioma	0.00042	0.0124	CcSEcCtD
Pethidine—Tremor—Temozolomide—malignant glioma	0.000414	0.0122	CcSEcCtD
Pethidine—ALB—brain—malignant glioma	0.000409	0.00382	CbGeAlD
Pethidine—Agitation—Temozolomide—malignant glioma	0.000406	0.0119	CcSEcCtD
Pethidine—Vertigo—Temozolomide—malignant glioma	0.000397	0.0117	CcSEcCtD
Pethidine—SLC6A4—brain—malignant glioma	0.000397	0.00371	CbGeAlD
Pethidine—Convulsion—Carmustine—malignant glioma	0.000396	0.0117	CcSEcCtD
Pethidine—Hypertension—Carmustine—malignant glioma	0.000395	0.0116	CcSEcCtD
Pethidine—Palpitations—Temozolomide—malignant glioma	0.000391	0.0115	CcSEcCtD
Pethidine—Anxiety—Carmustine—malignant glioma	0.000388	0.0114	CcSEcCtD
Pethidine—Convulsion—Temozolomide—malignant glioma	0.000383	0.0113	CcSEcCtD
Pethidine—Hypertension—Temozolomide—malignant glioma	0.000382	0.0112	CcSEcCtD
Pethidine—Confusional state—Carmustine—malignant glioma	0.000376	0.0111	CcSEcCtD
Pethidine—Anxiety—Temozolomide—malignant glioma	0.000375	0.011	CcSEcCtD
Pethidine—Oedema—Carmustine—malignant glioma	0.000373	0.011	CcSEcCtD
Pethidine—Dry mouth—Temozolomide—malignant glioma	0.000368	0.0108	CcSEcCtD
Pethidine—Tachycardia—Carmustine—malignant glioma	0.000364	0.0107	CcSEcCtD
Pethidine—Confusional state—Temozolomide—malignant glioma	0.000364	0.0107	CcSEcCtD
Pethidine—Anaphylactic shock—Temozolomide—malignant glioma	0.000361	0.0106	CcSEcCtD
Pethidine—Oedema—Temozolomide—malignant glioma	0.000361	0.0106	CcSEcCtD
Pethidine—Anorexia—Carmustine—malignant glioma	0.000356	0.0105	CcSEcCtD
Pethidine—SLC6A2—brain—malignant glioma	0.00035	0.00327	CbGeAlD
Pethidine—Hypotension—Carmustine—malignant glioma	0.000349	0.0103	CcSEcCtD
Pethidine—Hyperhidrosis—Temozolomide—malignant glioma	0.000349	0.0103	CcSEcCtD
Pethidine—Anorexia—Temozolomide—malignant glioma	0.000344	0.0101	CcSEcCtD
Pethidine—Insomnia—Carmustine—malignant glioma	0.000338	0.00993	CcSEcCtD
Pethidine—Somnolence—Carmustine—malignant glioma	0.000332	0.00976	CcSEcCtD
Pethidine—Insomnia—Temozolomide—malignant glioma	0.000326	0.00959	CcSEcCtD
Pethidine—Decreased appetite—Carmustine—malignant glioma	0.000325	0.00954	CcSEcCtD
Pethidine—CYP2B6—central nervous system—malignant glioma	0.000324	0.00303	CbGeAlD
Pethidine—Somnolence—Temozolomide—malignant glioma	0.000321	0.00943	CcSEcCtD
Pethidine—Constipation—Carmustine—malignant glioma	0.000319	0.00939	CcSEcCtD
Pethidine—Decreased appetite—Temozolomide—malignant glioma	0.000314	0.00922	CcSEcCtD
Pethidine—Constipation—Temozolomide—malignant glioma	0.000309	0.00907	CcSEcCtD
Pethidine—Feeling abnormal—Carmustine—malignant glioma	0.000308	0.00905	CcSEcCtD
Pethidine—Feeling abnormal—Temozolomide—malignant glioma	0.000297	0.00874	CcSEcCtD
Pethidine—Urticaria—Temozolomide—malignant glioma	0.000287	0.00843	CcSEcCtD
Pethidine—Hypersensitivity—Carmustine—malignant glioma	0.000275	0.00809	CcSEcCtD
Pethidine—Asthenia—Carmustine—malignant glioma	0.000268	0.00788	CcSEcCtD
Pethidine—Hypersensitivity—Temozolomide—malignant glioma	0.000266	0.00782	CcSEcCtD
Pethidine—Asthenia—Temozolomide—malignant glioma	0.000259	0.00761	CcSEcCtD
Pethidine—CYP2B6—brain—malignant glioma	0.000258	0.00241	CbGeAlD
Pethidine—Pruritus—Temozolomide—malignant glioma	0.000255	0.00751	CcSEcCtD
Pethidine—Dizziness—Carmustine—malignant glioma	0.000247	0.00726	CcSEcCtD
Pethidine—CYP3A4—central nervous system—malignant glioma	0.000245	0.00229	CbGeAlD
Pethidine—CYP2D6—central nervous system—malignant glioma	0.000241	0.00225	CbGeAlD
Pethidine—Dizziness—Temozolomide—malignant glioma	0.000239	0.00701	CcSEcCtD
Pethidine—Vomiting—Carmustine—malignant glioma	0.000237	0.00698	CcSEcCtD
Pethidine—CYP2D6—cerebellum—malignant glioma	0.000236	0.0022	CbGeAlD
Pethidine—Rash—Carmustine—malignant glioma	0.000235	0.00692	CcSEcCtD
Pethidine—Dermatitis—Carmustine—malignant glioma	0.000235	0.00691	CcSEcCtD
Pethidine—Headache—Carmustine—malignant glioma	0.000234	0.00688	CcSEcCtD
Pethidine—Vomiting—Temozolomide—malignant glioma	0.000229	0.00674	CcSEcCtD
Pethidine—Rash—Temozolomide—malignant glioma	0.000228	0.00669	CcSEcCtD
Pethidine—Dermatitis—Temozolomide—malignant glioma	0.000227	0.00668	CcSEcCtD
Pethidine—Headache—Temozolomide—malignant glioma	0.000226	0.00665	CcSEcCtD
Pethidine—Nausea—Carmustine—malignant glioma	0.000222	0.00652	CcSEcCtD
Pethidine—Nausea—Temozolomide—malignant glioma	0.000214	0.0063	CcSEcCtD
Pethidine—CYP2D6—brain—malignant glioma	0.000191	0.00179	CbGeAlD
Pethidine—CYP2D6—Metabolism—IDH2—malignant glioma	1.54e-05	0.000155	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP3—malignant glioma	1.54e-05	0.000155	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CG—malignant glioma	1.54e-05	0.000155	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CB—malignant glioma	1.54e-05	0.000154	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN2B—malignant glioma	1.53e-05	0.000154	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2C18—malignant glioma	1.52e-05	0.000153	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PTPN11—malignant glioma	1.51e-05	0.000152	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH2—malignant glioma	1.5e-05	0.000151	CbGpPWpGaD
Pethidine—ALB—Hemostasis—F2—malignant glioma	1.5e-05	0.000151	CbGpPWpGaD
Pethidine—ALB—Hemostasis—FN1—malignant glioma	1.5e-05	0.000151	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CD—malignant glioma	1.49e-05	0.00015	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTK2—malignant glioma	1.49e-05	0.000149	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—malignant glioma	1.48e-05	0.000148	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KNG1—malignant glioma	1.47e-05	0.000148	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.46e-05	0.000147	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HES1—malignant glioma	1.46e-05	0.000146	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.45e-05	0.000146	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NCOR1—malignant glioma	1.45e-05	0.000146	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—IDH1—malignant glioma	1.44e-05	0.000145	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CG—malignant glioma	1.44e-05	0.000144	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.44e-05	0.000144	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—RAF1—malignant glioma	1.43e-05	0.000144	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EGF—malignant glioma	1.42e-05	0.000143	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—malignant glioma	1.41e-05	0.000142	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PTPN11—malignant glioma	1.41e-05	0.000142	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT2—malignant glioma	1.41e-05	0.000142	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NTRK1—malignant glioma	1.4e-05	0.000141	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CB—malignant glioma	1.4e-05	0.00014	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SPHK1—malignant glioma	1.4e-05	0.00014	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDGFRA—malignant glioma	1.39e-05	0.000139	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.37e-05	0.000138	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.37e-05	0.000137	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	1.36e-05	0.000136	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SPP1—malignant glioma	1.35e-05	0.000135	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	1.34e-05	0.000135	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ASMT—malignant glioma	1.33e-05	0.000134	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—IDH1—malignant glioma	1.33e-05	0.000133	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT2—malignant glioma	1.32e-05	0.000132	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.31e-05	0.000131	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP3—malignant glioma	1.3e-05	0.000131	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.3e-05	0.000131	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	1.3e-05	0.000131	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	1.29e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.29e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.29e-05	0.000129	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—malignant glioma	1.28e-05	0.000129	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—malignant glioma	1.28e-05	0.000128	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—BCHE—malignant glioma	1.28e-05	0.000128	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CD—malignant glioma	1.26e-05	0.000127	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.26e-05	0.000127	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.26e-05	0.000126	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.26e-05	0.000126	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTK2—malignant glioma	1.26e-05	0.000126	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BCAN—malignant glioma	1.25e-05	0.000126	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	1.25e-05	0.000125	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDGFB—malignant glioma	1.25e-05	0.000125	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGFR1—malignant glioma	1.24e-05	0.000125	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HES1—malignant glioma	1.23e-05	0.000124	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTT1—malignant glioma	1.23e-05	0.000124	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NCOR1—malignant glioma	1.23e-05	0.000123	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HIF1A—malignant glioma	1.22e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—RAF1—malignant glioma	1.21e-05	0.000121	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—malignant glioma	1.19e-05	0.00012	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CAV1—malignant glioma	1.18e-05	0.000119	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	1.18e-05	0.000119	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.18e-05	0.000118	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	1.17e-05	0.000118	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—malignant glioma	1.17e-05	0.000117	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS1—malignant glioma	1.16e-05	0.000116	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.15e-05	0.000116	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SPP1—malignant glioma	1.14e-05	0.000114	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	1.14e-05	0.000114	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.13e-05	0.000114	CbGpPWpGaD
Pethidine—ALB—Hemostasis—RAF1—malignant glioma	1.13e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—F2—malignant glioma	1.13e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FN1—malignant glioma	1.13e-05	0.000113	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BAD—malignant glioma	1.11e-05	0.000112	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTT1—malignant glioma	1.11e-05	0.000111	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CB—malignant glioma	1.1e-05	0.000111	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	1.1e-05	0.000111	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—malignant glioma	1.09e-05	0.000109	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CD80—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APC—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	1.08e-05	0.000108	CbGpPWpGaD
Pethidine—ALB—Metabolism—BCHE—malignant glioma	1.07e-05	0.000108	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGF—malignant glioma	1.07e-05	0.000107	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.06e-05	0.000107	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC5A5—malignant glioma	1.06e-05	0.000106	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTPN11—malignant glioma	1.06e-05	0.000106	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFB—malignant glioma	1.06e-05	0.000106	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGFR1—malignant glioma	1.05e-05	0.000105	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.04e-05	0.000104	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—malignant glioma	1.03e-05	0.000104	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.03e-05	0.000104	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.02e-05	0.000102	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.02e-05	0.000102	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—malignant glioma	1.01e-05	0.000102	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—malignant glioma	1.01e-05	0.000102	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IDH2—malignant glioma	1.01e-05	0.000101	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1e-05	0.000101	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CAV1—malignant glioma	1e-05	0.0001	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.94e-06	9.98e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—malignant glioma	9.89e-06	9.92e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAT—malignant glioma	9.88e-06	9.91e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT2—malignant glioma	9.86e-06	9.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—malignant glioma	9.82e-06	9.85e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	9.77e-06	9.81e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—BCHE—malignant glioma	9.64e-06	9.68e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS1—malignant glioma	9.54e-06	9.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.53e-06	9.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FN1—malignant glioma	9.52e-06	9.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—F2—malignant glioma	9.52e-06	9.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.49e-06	9.53e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	9.47e-06	9.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BAD—malignant glioma	9.41e-06	9.44e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	9.38e-06	9.42e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NCOR1—malignant glioma	9.33e-06	9.36e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	9.31e-06	9.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—malignant glioma	9.28e-06	9.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CD80—malignant glioma	9.13e-06	9.16e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—malignant glioma	9.11e-06	9.14e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	9.11e-06	9.14e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGF2—malignant glioma	9.07e-06	9.1e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.01e-06	9.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGF—malignant glioma	9e-06	9.03e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTPN11—malignant glioma	8.95e-06	8.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.93e-06	8.96e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BCHE—malignant glioma	8.87e-06	8.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.76e-06	8.79e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IDH1—malignant glioma	8.68e-06	8.71e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.67e-06	8.7e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—malignant glioma	8.6e-06	8.63e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—malignant glioma	8.56e-06	8.59e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—malignant glioma	8.55e-06	8.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	8.52e-06	8.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—malignant glioma	8.49e-06	8.52e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAF1—malignant glioma	8.46e-06	8.49e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SPHK1—malignant glioma	8.4e-06	8.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—malignant glioma	8.37e-06	8.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT2—malignant glioma	8.33e-06	8.36e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAT—malignant glioma	8.32e-06	8.35e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—malignant glioma	8.3e-06	8.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	8.26e-06	8.29e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.23e-06	8.26e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	8.01e-06	8.03e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—malignant glioma	7.94e-06	7.96e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	7.93e-06	7.96e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NCOR1—malignant glioma	7.85e-06	7.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—malignant glioma	7.84e-06	7.87e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.78e-06	7.81e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—malignant glioma	7.67e-06	7.7e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF2—malignant glioma	7.67e-06	7.69e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	7.67e-06	7.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAV1—malignant glioma	7.61e-06	7.63e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—malignant glioma	7.6e-06	7.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—malignant glioma	7.58e-06	7.61e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAT—malignant glioma	7.47e-06	7.49e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—malignant glioma	7.31e-06	7.34e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	7.2e-06	7.23e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—malignant glioma	7.18e-06	7.2e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—malignant glioma	7.17e-06	7.2e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAF1—malignant glioma	7.15e-06	7.17e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—malignant glioma	7.14e-06	7.16e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—malignant glioma	7.07e-06	7.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.06e-06	7.08e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOR1—malignant glioma	7.05e-06	7.08e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	6.98e-06	7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—malignant glioma	6.96e-06	6.99e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.93e-06	6.95e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAT—malignant glioma	6.87e-06	6.89e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—malignant glioma	6.72e-06	6.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—malignant glioma	6.71e-06	6.73e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—malignant glioma	6.69e-06	6.71e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—malignant glioma	6.66e-06	6.68e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—malignant glioma	6.5e-06	6.52e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.49e-06	6.51e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	6.48e-06	6.5e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—malignant glioma	6.45e-06	6.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—malignant glioma	6.42e-06	6.44e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—malignant glioma	6.41e-06	6.43e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAV1—malignant glioma	6.4e-06	6.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—malignant glioma	6.38e-06	6.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.24e-06	6.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.12e-06	6.14e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.09e-06	6.11e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—malignant glioma	6.07e-06	6.09e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—malignant glioma	6.03e-06	6.05e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—malignant glioma	5.93e-06	5.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—malignant glioma	5.88e-06	5.9e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—malignant glioma	5.83e-06	5.85e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—malignant glioma	5.8e-06	5.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BCHE—malignant glioma	5.8e-06	5.82e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAV1—malignant glioma	5.75e-06	5.77e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.73e-06	5.75e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—malignant glioma	5.63e-06	5.65e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.49e-06	5.51e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—malignant glioma	5.49e-06	5.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—malignant glioma	5.48e-06	5.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—malignant glioma	5.45e-06	5.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—malignant glioma	5.39e-06	5.41e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.31e-06	5.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAV1—malignant glioma	5.29e-06	5.3e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.26e-06	5.28e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.24e-06	5.25e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—malignant glioma	5.13e-06	5.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—malignant glioma	5.05e-06	5.07e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	5.03e-06	5.05e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—malignant glioma	5.01e-06	5.03e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—malignant glioma	4.9e-06	4.92e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—malignant glioma	4.87e-06	4.89e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.82e-06	4.83e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—malignant glioma	4.65e-06	4.66e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—malignant glioma	4.63e-06	4.65e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.61e-06	4.63e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.6e-06	4.62e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—malignant glioma	4.59e-06	4.6e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAT—malignant glioma	4.49e-06	4.51e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—malignant glioma	4.47e-06	4.48e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—malignant glioma	4.43e-06	4.44e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	4.25e-06	4.27e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.24e-06	4.25e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.23e-06	4.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—malignant glioma	4.12e-06	4.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—malignant glioma	4.11e-06	4.13e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.01e-06	4.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.98e-06	3.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—malignant glioma	3.86e-06	3.87e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.69e-06	3.7e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.66e-06	3.67e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—malignant glioma	3.48e-06	3.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—malignant glioma	3.47e-06	3.48e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAV1—malignant glioma	3.46e-06	3.47e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.24e-06	3.25e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—malignant glioma	3.19e-06	3.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.15e-06	3.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—malignant glioma	3.04e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.77e-06	2.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—malignant glioma	2.72e-06	2.73e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—malignant glioma	2.64e-06	2.65e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.45e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.41e-06	2.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.39e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.25e-06	2.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—malignant glioma	2.23e-06	2.23e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—malignant glioma	2.08e-06	2.09e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—malignant glioma	2e-06	2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—malignant glioma	1.84e-06	1.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.47e-06	1.48e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—malignant glioma	1.2e-06	1.21e-05	CbGpPWpGaD
